(Last updated: September 2021)

Appendix B: Panel Roster and Financial Disclosures

PML/JCV

Progressive Multifocal Leukoencephalopathy
Member Institution Financial Disclosure
Company Relationship
Shruti Agnihotri The University of Alabama at Birmingham, School of Medicine Moderna

Pfizer

Gilead Sciences

Johnson & Johnson
Equity Interest
Paola Cinque San Raffaele Scientific Institute, Milan, Italy Janssen Consultant
Cellevolve Scientific Advisory Board
Gilead Sciences

ViiV Healthcare
Research Support (paid to institution)
David Clifford* Washington University in St. Luis, School of Medicine Roche

Takeda

Seattle Genetics

Arena Pharmaceuticals
Scientific Advisory Board

Wave Life Sciences

Excision BioTherapeutics, Inc.

Sanofi Genzyme

Atara BioTherapeutics, Inc.

Data Safety Monitoring Board
Irene Cortese National Institutes of Health Nouscom AG

Keires AG

PDC*line Pharma

Life Sciences

Partners CV
Equity interest
Christina Marra University of Washington, School of Medicine None N/A
Jose M. Miro Hospital Clinic-IDIBAPS, University of Barcelona, Spain None N/A
* Group lead

Note:
Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting is from July 2021 through July 2022.

 

Download Guidelines